The renal dialysis market in South Korea is expected to grow at a compound annual growth rate (CAGR) of 12.5% between 2020 and 2025, driven by the increasing use of hemodialysis machines and peritoneal dialysis (PD) for the treatment of end-stage renal disease (ESRD). Hemodialysis machines accounted for more than 90% of the South Korean renal dialysis market in 2020.
Fresenius SE & Co KGaA was the leading player in the South Korean renal dialysis market in 2020, followed by B. Braun Melsungen AG. Together these two companies accounted for around 55% of the total market in 2020.
Anusha Kaushik, Medical Devices Analyst at GlobalData, comments: “With increase in the number of COVID-19 cases during the onset of the pandemic, people suffering from ESRD were impacted as they require regular dialysis care to survive. During the pandemic, patients had access to dialysis centers and home-based equipment for continuous treatment. This has kept the demand afloat for renal dialysis equipment.”
Patients with renal disease will have weakened immune system and require continuous care as they are more susceptible to the virus. Increase in the aging population, high prevalence of diabetes mellitus, hypertension and vascular diseases are leading to the growth of ESRD, which in turn is driving the demand for renal dialysis equipment.
Dialysis treatment is preferred over transplant procedure for patients suffering from ESRD due to the shortage of donors and complexities associated with transplant procedure. The frequent need for dialysis and adoption of advanced technologies in medical institutions and development of better home dialysis equipment are expected to further boost the growth of renal dialysis equipment market in South Korea.
Ms. Kaushik concludes: “The use of hemodialysis machines is high in South Korea. However, the growing demand for home-based care, increasing awareness of peritoneal dialysis, relatively high cost of hemodialysis at dialysis centers are expected to lead to the higher adoption rate of peritoneal dialysis in the future.”
Who should buy this report?
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
CMO executives who must have deep understanding of the Renal Dialysis Machines marketplace to make strategic planning and investment decisions.
Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Currently marketed Renal Dialysis Machines and evolving competitive landscape:
Insightful review of the key industry trends.
Annualized total Renal Dialysis Machines market revenue by segment and market outlooks from 2015-2030.
Granular data on total procedures, units, average selling prices and market values by segment.
Reasons to buy
The model will enable you to:
Understand the impact of COVID-19 on Renal Dialysis Machines market.
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving Renal Dialysis Machines market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Renal Dialysis Machines market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Track device sales in the global and country-specific Renal Dialysis Machines market from 2015-2030.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Fresenius Medical Care AG & Co KGaA
Baxter International Inc
Nikkiso Co Ltd
B. Braun Melsungen AG